Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma exchange as therapy for disseminated intravascular coagulation (DIC)
2010-024263-40Phase 3Terminated
- Sponsor
- Medical University of Vienna
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of octaplas lg in disseminated intravascular coagulation (DIC) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: 28 day mortality. Started Aug 2011; status: terminated.
02
Drugs
octaplas lg
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on 2010-024263-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024263-40.